These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35887565)

  • 21. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis.
    Sin DD; Man J; Sharpe H; Gan WQ; Man SF
    JAMA; 2004 Jul; 292(3):367-76. PubMed ID: 15265853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics and pharmacogenetics of the leukotriene pathway.
    Tantisira KG; Drazen JM
    J Allergy Clin Immunol; 2009 Sep; 124(3):422-7. PubMed ID: 19665766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenomics of pediatric asthma.
    Gupta S; Awasthi S
    Indian J Hum Genet; 2010 Sep; 16(3):111-8. PubMed ID: 21206697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of 927T > C CYSLTR1 and -444A > C LTC4S polymorphisms in children with asthma.
    Arriba-Méndez S; Sanz C; Isidoro-García M; Pascual M; Avila C; Dávila I; Lorente F
    Allergol Immunopathol (Madr); 2008; 36(5):259-63. PubMed ID: 19080797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma.
    Edmonds ML; Milan SJ; Camargo CA; Pollack CV; Rowe BH
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD002308. PubMed ID: 23235589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacogenetics and pharmacogenomics of asthma therapy.
    Tse SM; Tantisira K; Weiss ST
    Pharmacogenomics J; 2011 Dec; 11(6):383-92. PubMed ID: 21987090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci.
    Tantisira KG; Lima J; Sylvia J; Klanderman B; Weiss ST
    Pharmacogenet Genomics; 2009 Mar; 19(3):244-7. PubMed ID: 19214143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.
    Ng D; Salvio F; Hicks G
    Cochrane Database Syst Rev; 2004; (2):CD002314. PubMed ID: 15106175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukotriene pathway polymorphisms are associated with altered cysteinyl leukotriene production in children with acute asthma.
    Bizzintino JA; Khoo SK; Zhang G; Martin AC; Rueter K; Geelhoed GC; Goldblatt J; Laing IA; Le Souëf PN; Hayden CM
    Prostaglandins Leukot Essent Fatty Acids; 2009 Jul; 81(1):9-15. PubMed ID: 19524426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment response heterogeneity in asthma: the role of genetic variation.
    Vijverberg SJH; Farzan N; Slob EMA; Neerincx AH; Maitland-van der Zee AH
    Expert Rev Respir Med; 2018 Jan; 12(1):55-65. PubMed ID: 29115880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews.
    Craig SS; Dalziel SR; Powell CV; Graudins A; Babl FE; Lunny C
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012977. PubMed ID: 32767571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast.
    Klotsman M; York TP; Pillai SG; Vargas-Irwin C; Sharma SS; van den Oord EJ; Anderson WH
    Pharmacogenet Genomics; 2007 Mar; 17(3):189-96. PubMed ID: 17460547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth.
    Axelsson I; Naumburg E; Prietsch SO; Zhang L
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD010126. PubMed ID: 31194879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship between the efficacy of inhaled corticosteroids and the leukotriene expression in children with asthma].
    Wu JL; Chen AH; Peng QY; Chen RC; Zhong NS
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):441-4. PubMed ID: 19558806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth.
    Pruteanu AI; Chauhan BF; Zhang L; Prietsch SO; Ducharme FM
    Evid Based Child Health; 2014 Dec; 9(4):931-1046. PubMed ID: 25504973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of leukotriene receptor antagonists in addition to inhaled corticosteroid and inhaled corticosteroid alone in the treatment of adolescents and adults with bronchial asthma: a meta-analysis.
    Cao Y; Wang J; Bunjhoo H; Xie M; Xu Y; Fang H
    Asian Pac J Allergy Immunol; 2012 Jun; 30(2):130-8. PubMed ID: 22830292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukotriene modifiers for asthma treatment.
    Montuschi P; Peters-Golden ML
    Clin Exp Allergy; 2010 Dec; 40(12):1732-41. PubMed ID: 21059119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CMTR1 is associated with increased asthma exacerbations in patients taking inhaled corticosteroids.
    Dahlin A; Denny J; Roden DM; Brilliant MH; Ingram C; Kitchner TE; Linneman JG; Shaffer CM; Weeke P; Xu H; Kubo M; Tamari M; Clemmer GL; Ziniti J; McGeachie MJ; Tantisira KG; Weiss ST; Wu AC
    Immun Inflamm Dis; 2015 Dec; 3(4):350-9. PubMed ID: 26734457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to Control Asthma with Personalized Management: Where Do We Stand Now?
    Wang M; Yao Y; Jiang S; Tao F; Tang R; Sun J
    Curr Drug Metab; 2018; 19(14):1188-1198. PubMed ID: 29380695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.